SZSE:300204 (China)
Â
Class A
Â¥
5.55
(-6.09%)
Jun 24
New Key Statistics Module, Z-Score and F-Score
SZSE:300204 Key Ratios
Market Cap ¥ M | 2,651.64 |
Enterprise Value ¥ M | 2,789.48 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.58 |
Price/Sales | 6.26 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 394.00 |
EPS (TTM) ¥ | -0.75 |
Beneish M-Score | -3.51 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.71 |
EV-to-EBITDA | -8.71 |
PEG | -- |
Shares Outstanding M | 477.77 |
Net Margin (%) | -89.80 |
Operating Margin % | -79.22 |
Pre-tax Margin (%) | -81.57 |
Quick Ratio | 1.02 |
Current Ratio | 1.13 |
ROA % (ttm) | -24.58 |
ROE % (ttm) | -30.90 |
ROIC % (ttm) | -28.61 |
Dividend Yield % | -- |
Altman Z-Score | 5.23 |
SZSE:300204 Number of Guru Trades
SZSE:300204 Volume of Guru Trades
Gurus Latest Trades with SZSE:300204
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300204 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Staidson (Beijing) Biopharmaceuticals Co Ltd Insider Transactions
No Available Data